UPDATED 20.02.2014 13:16

Organised cervical cancer screening programme in Finland in the invitation year 2009. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 348 municipalities (out of 348).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 182035 1431 0.79 24 0.01 1 0.00 38 0.02 192 0.11 185 0.10 145 0.08 846 0.46
I 171034 8 0.00 1 0.00 - - - - - - - - - - 7 0.00
II 9861 295 0.16 2 0.00 - - 1 0.00 7 0.00 12 0.01 27 0.01 246 0.14
III 1024 1018 0.56 12 0.01 - - 28 0.02 131 0.07 157 0.09 114 0.06 576 0.32
IV 107 107 0.06 6 0.00 1 0.00 9 0.00 54 0.03 16 0.01 4 0.00 17 0.01
V 3 3 0.00 3 0.00 - - - - - - - - - - - -
Inadequate 6 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 7012 210 2.99 - - - - 3 0.04 8 0.11 25 0.36 20 0.29 154 2.20
Negative1 6413 - - - - - - - - - - - - - - - -
Positive2 599 210 2.99 - - - - 3 0.04 8 0.11 25 0.36 20 0.29 154 2.20
Total 189047 1641 0.87 24 0.01 1 0.00 41 0.02 200 0.11 210 0.11 165 0.09 1000 0.53

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.